News

Omrix is expected to operate as a stand-alone entity reporting through Ethicon, a Johnson & Johnson company.

The minimum tender condition was reduced to the number of Genelabs’s shares that when added to the maximum number of Genelabs’s shares issuable in the top-up option equals

Stavudine capsules 15mg, 20mg, 30mg and 40mg and Stavudine for oral solution 1mg/ml are the generic equivalent of Bristol-Myers Squibb Company’s Zerit 15mg, 20mg, 30mg and 40mg and

This agreement, in effect, settles the issues identified by the Department of Justice in its previously filed complaint against the company, Actavis Totowa, and officers Sigurdur Olafsson and

The acquisition is said to complement Moog’s current medical devices product line. This acquisition is expected to be neutral to Moog’s earnings per share for the year ending

iCAD has received CE mark approval to market and sell its customized solution with Planmed Nuance mammography systems and units have been placed at Terveystalo Breast Cancer Screening

Under the terms of purchase agreements, XenoPort will sell 1.89 million newly issued shares of its common stock and warrants to purchase 283,420 shares of common stock at

Joseph Army, president and CEO of Salient, said: “This new facility provides exciting opportunities for our continued growth. It brings many new capabilities to our corporate office, including

The funds will be used for general corporate purposes. The financing gives the company the right to place common stock to the investors at a 3% discount to